ACLX Chart
- 52-Week Range: $7.21 - $33.94
- Market Capitalization: $1.55B
- Short Percentage: 0%
- Target Price: $37.33
- Shares Outstanding: 43.85M
- Next Earnings: Mar 23
Catalysts
ACLX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
ACLX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
ACLX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
ACLX will release their earnings report for the previous quarter and provide guidance for the current and upcoming quarters.
News and Press Releases
- Arcellx flies on $325M deal with Gilead's Kite for multiple myeloma treatmentProactive Investors | December 9th
- Arcellx Announces Participation at the Morgan Stanley 20th Annual Global Healthcare ConferencePRNewsWire | September 7th
Company Info
Address: 25 West Watkins Mill Road, Gaithersburg, MD, United States, 20878
Sector: Healthcare
Industry: Biotechnology
Full time employees: 78
$ACLX God dammit
$ACLX has just been halted from trading.
$ACLX let it ride
$ACLX come on I wana jump up and down
$ACLX has just been halted from trading due to volatility.